Skip to main content

Table 1 Comorbidities under treatment at baseline and after 12 months aspiration therapy

From: Aspiration therapy for obesity; a safe and effective treatment

Comorbidities under treatment

Number of subjects

Baseline, all subjects

n = 25

Baseline, per protocol

n = 20

12 months, per protocol

n = 20

Diabetes mellitus type 2 (total)

7

7

5

 - Diet treatment

2

2

2

 - Metformin

4

4

2

 - Metformin + insulin

1

1

1

Hypertension (total)

9

8

7

 - Diuretic

6

5

4

 - ACE-inhibitor

5

5

4

 - Beta receptor antagonist

3

3

3

Hyperlipidemia (total)

2

2

2

 - Statin

2

2

2

Mood disorder (total)

9

6

6

 - SSRI

8

6

6

 - Tricyclic antidepressant

1

0

0

Gastroesophageal reflux disease

2

2

3

 - Omeprazole

2

2

3